TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new drug discovery business unit to leverage its capabilities and expand upon the utility of the HTG EdgeSeq […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointments of Brian Stolz as Chief People Officer, Diana King as Vice President of Customer Support, and Jordan Neysmith as Vice President of Engineering. The new leadership appointments follow the recent close of $276 million in Series C financing and support […]
Through a new distribution agreement, Lonza will supply a selection of cells to be prequalified for use in CN Bio’s innovative PhysioMimix™ Organ-On-a-Chip (OOC) range of Single- and Multi-organ Microphysiological Systems (MPS) The companies share a common goal of developing and supplying advanced cell models that better reflect an in vivo environment to improve drug discovery accuracy […]
CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell line development (CLD). […]
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif. — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system*. Using proprietary Ion AmpliSeq […]
Summa Equity Fund II has acquired Axion BioSystems, a US life science tools business specializing in the development, production, and marketing of MEA (Microelectrode Arrays) and impedance technologies. Its tools are used to understand cell behavior and function in real-time, for applications including cell and gene therapy (CGT). Stockholm, Sweden: Summa Equity Fund II (“Summa”) has […]
Expanding initiative focused on next generation sequencing services tailored to research needs CORALVILLE, Iowa — Integrated DNA Technologies, Inc. (IDT), a leading comprehensive genomics research solutions provider, has added Predicine to the IDT Align Program. This move expands the program’s roster of preferred sequencing providers. The combination of IDT’s high quality and flexible next generation sequencing (NGS) […]
Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif. — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis. The new Series comprises the Chromium X, the company’s most powerful instrument yet […]
Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company
Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company – Celemics enters the Chinese DNA Sequencing market since its establishment – NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time – The agreement scale is equivalent to 87% in celemics’ annual revenue Seoul, Korea: Celemics, […]
Seoul, South Korea – South Korea-based Sanigen has announced that it will become a regional distributor for Illumina, the world’s leading genome sequencing company. The partners will work together to bring Illumina’s NGS platform technology to the food safety and microbiology sectors in South Korea. Sanigen is a company specializing in food safety South Korea and serves the market […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
